Tunstall Demonstrates Latest Innovations in Telehealthcare at Commissioning 2013

TunstallTunstall Healthcare, the leading provider of telehealth and telecare solutions, is showcasing its latest innovations to transform healthcare by supporting patient self-management and successfully delivering telehealth at scale at Commissioning 2013.

Tunstall's key focus at the event is its 5 Steps to Telehealth Success programme, a robust implementation process which helps health providers to ensure that telehealth is deployed successfully to the right patients, and embedded within care pathways. Tunstall provides dedicated, clinical support throughout the telehealth journey, from engagement to deployment and governance.

The 5 step approach covers care pathway optimisation, patient identification and risk stratification, clinical review and care planning, referral generation, and post-deployment review and support. This ensures positive outcomes for patients and clinicians, and accelerates financial returns.

Tunstall will also be demonstrating its latest mymedic II home telehealth system, which is designed to help people with long-term health needs to monitor their own conditions from home. The device enables users to easily self-monitor their vital signs to ensure timely intervention, while enhancing understanding of their health.

Designed specifically for the needs of patients with poor dexterity and eyesight, the system's touchscreen tablet design gives easy access to functions and offers limitless flexibility for future applications, while Bluetooth technology makes the process of sharing information faster and more efficient. New peripherals for mymedic II include a blood pressure monitor, pulse oximeter and weighing scales, enabling the solution to help manage a range of long-term conditions.

Tunstall is working together with risk stratification provider Health Intelligence to enhance and support the delivery of its fully managed telehealthcare service, Tunstall LifeCare. A proven risk stratification process is essential for delivering an effective telehealthcare service at scale, as it identifies the most appropriate patients for the service, accelerating benefits to service users and maximising care provision and ROI for the provider.

Tunstall LifeCare and Health Intelligence’s population-based Risk Stratification and Case Finding modules offer local commissioners a robust, secure and rapidly deployable solution that helps the NHS to improve diagnosis, promote prevention and deliver cost savings.

David Cockayne, Managed Services Director said: "For telehealth programmes to be truly successful at scale, it's important that each patient is carefully selected based on specific criteria and thresholds. Commissioning 2013 is a great opportunity for us to showcase how our advanced solutions and services and our partnership with Health Intelligence can help commissioners and clinicians in identifying the patients who will benefit most from telehealth, and deliver the most positive outcomes for patients, clinicians and commissioners."

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, helping them to live independently by effectively managing their health and well-being. Its solutions have been proven effective in the world's largest telehealthcare trial. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...